JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6726
Hycroft Mining Holding Corp
HYMC
$1.74B
| $66 | ﹤0.01% |
30
| – | – |
2022 Q2
7 quarters
|
|
6727
NeuroOne Medical Technologies
NMTC
$10.2M
| $66 | ﹤0.01% |
9
+2
| +29% | +$15 |
2023 Q3
2 quarters
|
|
|
GRDI
6728
DELISTED
GRIID Infrastructure Inc. Common Stock
GRDI
| $66 | ﹤0.01% |
+50
| New | +$101 |
2024 Q1
0 quarters
|
|
|
GMDA
6729
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $66 | ﹤0.01% |
1,838
| – | – |
2020 Q4
13 quarters
|
|
|
TBHC
6730
DELISTED
The Brand House Collective
TBHC
| $65 | ﹤0.01% |
27
+8
| +42% | +$22 |
2023 Q4
1 quarter
|
|
6731
Unicycive Therapeutics
UNCY
$118M
| $65 | ﹤0.01% |
+5
| New | +$61 |
2024 Q1
0 quarters
|
|
|
VIVS
6732
VivoSim Labs
VIVS
$2.63M
| $65 | ﹤0.01% |
5
| – | – |
2015 Q4
33 quarters
|
|
6733
Veru
VERU
$42.8M
| $64 | ﹤0.01% |
9
| – | – |
2018 Q1
24 quarters
|
|
|
BMTX
6734
DELISTED
BM Technologies, Inc.
BMTX
| $64 | ﹤0.01% |
39
+4
| +11% | +$8 |
2023 Q1
4 quarters
|
|
6735
Global X Russell 2000 Covered Call ETF
RYLD
$1.33B
| $63 | ﹤0.01% |
3,758
+3,757
| +375,700% | +$62.1K |
2023 Q4
1 quarter
|
|
|
EARN
6736
Ellington Residential Mortgage REIT
EARN
$151M
| $62 | ﹤0.01% |
9
-14,384
| -100% | -$88.5K |
2020 Q2
15 quarters
|
|
6737
Hennessy Advisors
HNNA
$81.5M
| $62 | ﹤0.01% |
9
+3
| +50% | +$21 |
2023 Q3
2 quarters
|
|
6738
Lipocine
LPCN
$16.9M
| $62 | ﹤0.01% |
12
+3
| +33% | +$12 |
2019 Q1
20 quarters
|
|
6739
Orion Energy Systems
OESX
$124M
| $62 | ﹤0.01% |
7
+2
| +40% | +$20 |
2022 Q4
5 quarters
|
|
6740
RF Industries
RFIL
$91.1M
| $62 | ﹤0.01% |
20
+6
| +43% | +$19 |
2023 Q3
2 quarters
|
|
|
ANSC
6741
DELISTED
Agriculture & Natural Solutions Acquisition Corp
ANSC
| $61 | ﹤0.01% |
+6
| New | +$61 |
2024 Q1
0 quarters
|
|
6742
NetSol Technologies
NTWK
$71.1M
| $61 | ﹤0.01% |
22
+7
| +47% | +$18 |
2023 Q3
2 quarters
|
|
|
OMCC
6743
DELISTED
Old Market Capital Corp
OMCC
| $61 | ﹤0.01% |
9
+3
| +50% | +$21 |
2023 Q3
2 quarters
|
|
|
VBIV
6744
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $61 | ﹤0.01% |
100
+11
| +12% | +$7 |
2019 Q2
19 quarters
|
|
|
BCLI
6745
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $60 | ﹤0.01% |
7
+2
| +40% | +$11 |
2023 Q1
4 quarters
|
|
6746
Creative Realities
CREX
$33.8M
| $60 | ﹤0.01% |
16
+5
| +45% | +$17 |
2023 Q3
2 quarters
|
|
6747
Network-1 Technologies
NTIP
$37.3M
| $60 | ﹤0.01% |
29
+6
| +26% | +$13 |
2023 Q4
1 quarter
|
|
6748
CPI Aerostructures
CVU
$68.5M
| $59 | ﹤0.01% |
25
+6
| +32% | +$16 |
2023 Q3
2 quarters
|
|
6749
Gaia
GAIA
$35.3M
| $59 | ﹤0.01% |
19
-110
| -85% | -$321 |
2023 Q3
2 quarters
|
|
6750
RAVE Restaurant Group
RAVE
$32.8M
| $59 | ﹤0.01% |
27
+9
| +50% | +$18 |
2023 Q3
2 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.